CN Patent

CN112386565B — 一种马钱子碱凝胶制剂及其制备方法

Assigned to Beijing Increasepharm Co ltd · Expires 2024-09-13 · 2y expired

What this patent protects

本发明属于药物制剂领域，具体涉及一种马钱子碱凝胶制剂及其制备方法。该凝胶制剂包含0.5％‑1％的马钱子碱，0.5％‑3％凝胶骨架，10％‑30％助溶剂，余量为水。制备得到的马钱子碱水凝胶，使用简单的药用辅料，不使用透皮促进剂但透皮效果优异，易涂展，生物相溶性好、皮肤吸收良好、药膜附着性好、对皮肤和黏膜无刺激性。

USPTO Abstract

本发明属于药物制剂领域，具体涉及一种马钱子碱凝胶制剂及其制备方法。该凝胶制剂包含0.5％‑1％的马钱子碱，0.5％‑3％凝胶骨架，10％‑30％助溶剂，余量为水。制备得到的马钱子碱水凝胶，使用简单的药用辅料，不使用透皮促进剂但透皮效果优异，易涂展，生物相溶性好、皮肤吸收良好、药膜附着性好、对皮肤和黏膜无刺激性。

Drugs covered by this patent

Patent Metadata

Patent number
CN112386565B
Jurisdiction
CN
Classification
—
Expires
2024-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Increasepharm Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.